Would you rather be poked with a needle, or get a diagnosis from a non-invasive scan? Most of us would choose the latter, if we had the option.  Needle biopsies also come with the risk of infection and other complications that can be avoided by obtaining a diagnosis via imaging. Those are just some of the advantages underpinning the work of Perspectum, a global precision health company focused on improving the diagnosis, treatment, and management of metabolic diseases and cancer.  As founder and CEO Dr. Rajarshi Banerjee explains to host Michael Carrese, “I can work out with incredible clarity what kind of prostate cancer someone has, and what treatment they're likely to respond to, just from a scan.” Other applications include diagnosing and monitoring liver disease, and more recently, doing multi-organ scans to aid in evaluating long COVID.  Banerjee also sees a role for Perspectum’s computer-assisted imaging technology in combatting the rising tide of chronic disease in the U.S. “Unless we do something about them, there is going to be a fourfold rise in breast, colon and liver cancer in the next two decades.”  Check out this enlightening look at new tools to help providers customize treatments and provide better care for patients. 

Mentioned in this episode: Would you rather be poked with a needle, or get a diagnosis from a non-invasive scan? Most of us would choose the latter, if we had the option.  Needle biopsies also come with the risk of infection and other complications that can be avoided by obtaining a diagnosis via imaging. Those are just some of the advantages underpinning the work of Perspectum, a global precision health company focused on improving the diagnosis, treatment, and management of metabolic diseases and cancer.  As founder and CEO Dr. Rajarshi Banerjee explains to host Michael Carrese, “I can work out with incredible clarity what kind of prostate cancer someone has, and what treatment they're likely to respond to, just from a scan.” Other applications include diagnosing and monitoring liver disease, and more recently, doing multi-organ scans to aid in evaluating long COVID.  Banerjee also sees a role for Perspectum’s computer-assisted imaging technology in combatting the rising tide of chronic disease in the U.S. “Unless we do something about them, there is going to be a fourfold rise in breast, colon and liver cancer in the next two decades.”  Check out this enlightening look at new tools to help providers customize treatments and provide better care for patients. 

Mentioned in this episode: https://www.perspectum.com

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast